Angiodynamics Stock Analysis
| ANGO Stock | USD 12.46 0.05 0.40% |
AngioDynamics is undervalued with Real Value of 13.25 and Target Price of 15.33. The main objective of AngioDynamics stock analysis is to determine its intrinsic value, which is an estimate of what AngioDynamics is worth, separate from its market price. There are two main types of AngioDynamics' stock analysis: fundamental analysis and technical analysis.
The AngioDynamics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. AngioDynamics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. AngioDynamics Stock trading window is adjusted to America/New York timezone.
AngioDynamics |
AngioDynamics Stock Analysis Notes
About 81.0% of the company shares are held by institutions such as insurance companies. The book value of AngioDynamics was presently reported as 5.09. The company has Price/Earnings To Growth (PEG) ratio of 1.87. AngioDynamics recorded a loss per share of 5.59. The entity had not issued any dividends in recent years. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company was founded in 1988 and is headquartered in Latham, New York. Angiodynamics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 760 people. For more info on AngioDynamics please contact James Clemmer at 518 795 1400 or go to https://www.angiodynamics.com.AngioDynamics Quarterly Total Revenue |
|
AngioDynamics Investment Alerts
| AngioDynamics is way too risky over 90 days horizon | |
| AngioDynamics appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 303.91 M. Net Loss for the year was (184.35 M) with profit before overhead, payroll, taxes, and interest of 151.36 M. | |
| AngioDynamics currently holds about 24.56 M in cash with (28.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31. | |
| Over 81.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: AngioDynamics Hits New 52-Week High Following Strong Earnings Report Market - HPBL |
AngioDynamics Upcoming and Recent Events
Earnings reports are used by AngioDynamics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 10th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 10th of July 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 31st of May 2023 Last Financial Announcement | View |
AngioDynamics Largest EPS Surprises
Earnings surprises can significantly impact AngioDynamics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2014-04-09 | 2014-02-28 | 0.09 | 0.08 | -0.01 | 11 | ||
2014-01-09 | 2013-11-30 | 0.07 | 0.06 | -0.01 | 14 | ||
2013-10-10 | 2013-08-31 | 0.03 | 0.04 | 0.01 | 33 |
AngioDynamics Environmental, Social, and Governance (ESG) Scores
AngioDynamics' ESG score is a quantitative measure that evaluates AngioDynamics' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of AngioDynamics' operations that may have significant financial implications and affect AngioDynamics' stock price as well as guide investors towards more socially responsible investments.
AngioDynamics Thematic Classifications
In addition to having AngioDynamics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Cancer FightersPublic companies from health care and pharmaceutical sectors that are focused on fighting cancer |
AngioDynamics Stock Institutional Investors
| Shares | State Street Corp | 2024-09-30 | 810.4 K | Kent Lake Capital Llc | 2024-06-30 | 750 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 612.2 K | Jpmorgan Chase & Co | 2024-09-30 | 553.2 K | Assenagon Asset Management Sa | 2024-09-30 | 425.1 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 414.1 K | Acuitas Investments, Llc | 2024-09-30 | 403.3 K | Arnhold & S. Bleichroeder Advisers, Llc | 2024-09-30 | 394.1 K | Two Sigma Advisers, Llc | 2024-09-30 | 382.2 K | Blackrock Inc | 2024-09-30 | 4.7 M | Systematic Financial Management Lp | 2024-09-30 | 2.4 M |
AngioDynamics Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 504.2 M.AngioDynamics Profitablity
The company has Profit Margin (PM) of (0.83) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.13) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.13.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.88) | (0.84) | |
| Return On Capital Employed | (0.98) | (0.93) | |
| Return On Assets | (0.67) | (0.63) | |
| Return On Equity | (0.81) | (0.77) |
Management Efficiency
AngioDynamics has return on total asset (ROA) of (0.0612) % which means that it has lost $0.0612 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7785) %, meaning that it created substantial loss on money invested by shareholders. AngioDynamics' management efficiency ratios could be used to measure how well AngioDynamics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of January 2025, Return On Tangible Assets is likely to grow to -0.84. In addition to that, Return On Capital Employed is likely to grow to -0.93. At this time, AngioDynamics' Intangibles To Total Assets are very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.60 | 4.37 | |
| Tangible Book Value Per Share | 3.67 | 3.19 | |
| Enterprise Value Over EBITDA | (11.55) | (10.97) | |
| Price Book Value Ratio | 1.11 | 1.17 | |
| Enterprise Value Multiple | (11.55) | (10.97) | |
| Price Fair Value | 1.11 | 1.17 | |
| Enterprise Value | 165.1 M | 156.8 M |
At AngioDynamics, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Technical Drivers
As of the 30th of January, AngioDynamics shows the mean deviation of 3.04, and Risk Adjusted Performance of 0.1487. AngioDynamics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.AngioDynamics Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. AngioDynamics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for AngioDynamics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
AngioDynamics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AngioDynamics insiders, such as employees or executives, is commonly permitted as long as it does not rely on AngioDynamics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases AngioDynamics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
AngioDynamics Outstanding Bonds
AngioDynamics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. AngioDynamics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most AngioDynamics bonds can be classified according to their maturity, which is the date when AngioDynamics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
AngioDynamics Predictive Daily Indicators
AngioDynamics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AngioDynamics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
AngioDynamics Corporate Filings
F4 | 17th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 16th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 8th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 4th of December 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 15th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 8th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 23rd of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 10th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
AngioDynamics Forecast Models
AngioDynamics' time-series forecasting models are one of many AngioDynamics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AngioDynamics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About AngioDynamics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how AngioDynamics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AngioDynamics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as AngioDynamics. By using and applying AngioDynamics Stock analysis, traders can create a robust methodology for identifying AngioDynamics entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.73) | (0.69) | |
| Operating Profit Margin | (0.73) | (0.69) | |
| Net Loss | (0.70) | (0.66) | |
| Gross Profit Margin | 0.51 | 0.59 |
Current AngioDynamics Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AngioDynamics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. AngioDynamics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 15.33 | Strong Buy | 3 | Odds |
Most AngioDynamics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand AngioDynamics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of AngioDynamics, talking to its executives and customers, or listening to AngioDynamics conference calls.
AngioDynamics Stock Analysis Indicators
AngioDynamics stock analysis indicators help investors evaluate how AngioDynamics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading AngioDynamics shares will generate the highest return on investment. By understating and applying AngioDynamics stock analysis, traders can identify AngioDynamics position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 44.6 M | |
| Common Stock Shares Outstanding | 40.2 M | |
| Total Stockholder Equity | 205.6 M | |
| Tax Provision | -7.3 M | |
| Property Plant And Equipment Net | 41.5 M | |
| Cash And Short Term Investments | 76.1 M | |
| Cash | 76.1 M | |
| Accounts Payable | 37.8 M | |
| Net Debt | -71.3 M | |
| 50 Day M A | 9.282 | |
| Total Current Liabilities | 91.2 M | |
| Other Operating Expenses | 496.3 M | |
| Non Current Assets Total | 124.4 M | |
| Forward Price Earnings | 96.1538 | |
| Non Currrent Assets Other | 5.6 M | |
| Stock Based Compensation | 10.5 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.59) | Revenue Per Share | Quarterly Revenue Growth (0.14) | Return On Assets | Return On Equity |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.